Daclizumab in active relapsing multiple sclerosis (CHOICE study): a phase 2, randomised, double-blind, placebo-controlled, add-on trial with interferon beta
Autor: | Wynn, Daniel, Kaufman, Michael, Montalban, Xavier, Vollmer, Timothy, Simon, Jack, Elkins, Jacob, O'Neill, Gilmore, Neyer, Lauri, Sheridan, James, Wang, Chungchi, Fong, Alice, Rose, John W |
---|---|
Zdroj: | In Lancet Neurology 2010 9(4):381-390 |
Databáze: | ScienceDirect |
Externí odkaz: |